{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:46:07Z","timestamp":1777495567268,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10096-024-05006-3","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T14:24:09Z","timestamp":1734704649000},"page":"549-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ciprofloxacin-susceptible but levofloxacin-resistant Pseudomonas aeruginosa clinical strains with Vitek\u00ae2: which mechanism involved and consequences in case of fluoroquinolone treatment?"],"prefix":"10.1007","volume":"44","author":[{"given":"Manon","family":"Robert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Ruffier d\u2019Epenoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axelle","family":"Paquin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Boutoille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Guillouzouic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Corvec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"5006_CR1","doi-asserted-by":"publisher","unstructured":"Reynolds D, Kollef M The epidemiology and Pathogenesis and treatment of Pseudomonas aeruginosa infections: an update. Drugs 2021 7; https:\/\/doi.org\/10.1007\/s40265-021-01635-6","DOI":"10.1007\/s40265-021-01635-6"},{"key":"5006_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","volume":"22","author":"LS Redgrave","year":"2014","unstructured":"Redgrave LS, Sutton SB, Webber MA, Piddock LJV (2014) Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol 22:438\u2013445. https:\/\/doi.org\/10.1016\/j.tim.2014.04.007","journal-title":"Trends Microbiol"},{"key":"5006_CR3","doi-asserted-by":"publisher","first-page":"1800141","DOI":"10.1002\/ardp.201800141","volume":"351","author":"HAA Ezelarab","year":"2018","unstructured":"Ezelarab HAA, Abbas SH, Hassan HA, Abuo-Rahma GE-DA (2018) Recent updates of fluoroquinolones as antibacterial agents. Arch Pharm (Weinheim) 351:1800141. https:\/\/doi.org\/10.1002\/ardp.201800141","journal-title":"Arch Pharm (Weinheim)"},{"key":"5006_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.patbio.2009.04.003","volume":"59","author":"L Cr\u00e9met","year":"2011","unstructured":"Cr\u00e9met L, Caroff N, Dauvergne S, Reynaud A, Lepelletier D, Corvec S (2011) Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital. Pathol Biol (Paris) 59:151\u2013156. https:\/\/doi.org\/10.1016\/j.patbio.2009.04.003","journal-title":"Pathol Biol (Paris)"},{"key":"5006_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/14787210.2018.1489721","volume":"16","author":"ER Ocheretyaner","year":"2018","unstructured":"Ocheretyaner ER, Park TE (2018) Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Expert Rev Anti Infect Ther 16:523\u2013530. https:\/\/doi.org\/10.1080\/14787210.2018.1489721","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5006_CR6","doi-asserted-by":"publisher","unstructured":"Jord\u00e1n-Chaves JDD, Lobato-Cano R, Casas-Ciria J, Freyre-Carillo C, Santotoribio JD, de-la-Rubia-Martin MF (2023) 15;S1198-743X(23)00598-0 In vitro susceptibility to delafloxacin of Pseudomonas aeruginosa with resistance to other quinolones (ciprofloxacin and levofloxacin). Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. https:\/\/doi.org\/10.1016\/j.cmi.2023.12.008","DOI":"10.1016\/j.cmi.2023.12.008"},{"key":"5006_CR7","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1128\/jcm.33.9.2233-2239.1995","volume":"33","author":"FC Tenover","year":"1995","unstructured":"Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH et al (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233\u20132239. https:\/\/doi.org\/10.1128\/jcm.33.9.2233-2239.1995","journal-title":"J Clin Microbiol"},{"key":"5006_CR8","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s10096-020-03873-0","volume":"39","author":"L Ruffier d\u2019Epenoux","year":"2020","unstructured":"Ruffier d\u2019Epenoux L, Arshad N, B\u00e9mer P, Juvin M-E, Le Gargasson G, Guillouzouic A et al (2020) Misidentification of Cutibacterium namnetense as Cutibacterium acnes among clinical isolates by MALDI-TOF VitekMS: usefulness of gyrB sequencing and new player in bone infections. Eur J Clin Microbiol Infect Dis off Publ Eur Soc Clin Microbiol 39:1605\u20131610. https:\/\/doi.org\/10.1007\/s10096-020-03873-0","journal-title":"Eur J Clin Microbiol Infect Dis off Publ Eur Soc Clin Microbiol"},{"key":"5006_CR9","unstructured":"mexR multidrug resistance operon repressor MexR [Pseudomonas aeruginosa PAO1] - Gene - NCBI [Internet]. [cited 2023 10]; https:\/\/www.ncbi.nlm.nih.gov\/gene\/877857"},{"key":"5006_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/crj.13262","volume":"15","author":"BC Millar","year":"2021","unstructured":"Millar BC, McCaughan J, Rendall JC, Moore JE (2021) Delafloxacin\u2013A novel fluoroquinolone for the treatment of ciprofloxacin-resistant Pseudomonas aeruginosa in patients with cystic fibrosis. Clin Respir J 15:116\u2013120. https:\/\/doi.org\/10.1111\/crj.13262","journal-title":"Clin Respir J"},{"key":"5006_CR11","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1128\/AAC.41.10.2289","volume":"41","author":"M Nakano","year":"1997","unstructured":"Nakano M, Deguchi T, Kawamura T, Yasuda M, Kimura M, Okano Y et al (1997) Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 41:2289\u20132291. https:\/\/doi.org\/10.1128\/AAC.41.10.2289","journal-title":"Antimicrob Agents Chemother"},{"key":"5006_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/AAC.44.3.710-712.2000","volume":"44","author":"S Jalal","year":"2000","unstructured":"Jalal S, Ciofu O, Hoiby N, Gotoh N, Wretlind B (2000) Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 44:710\u2013712. https:\/\/doi.org\/10.1128\/AAC.44.3.710-712.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"5006_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/mdr.1998.4.257","volume":"4","author":"S Jalal","year":"1998","unstructured":"Jalal S, Wretlind B (1998) Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa. Microb Drug Resist Larchmt N 4:257\u2013261. https:\/\/doi.org\/10.1089\/mdr.1998.4.257","journal-title":"Microb Drug Resist Larchmt N"},{"key":"5006_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/s0924-8579(03)00009-8","volume":"21","author":"PG Higgins","year":"2003","unstructured":"Higgins PG, Fluit AC, Milatovic D, Verhoef J, Schmitz F-J (2003) Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 21:409\u2013413. https:\/\/doi.org\/10.1016\/s0924-8579(03)00009-8","journal-title":"Int J Antimicrob Agents"},{"key":"5006_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ijantimicag.2012.06.021","volume":"40","author":"M Matsumoto","year":"2012","unstructured":"Matsumoto M, Shigemura K, Shirakawa T, Nakano Y, Miyake H, Tanaka K et al (2012) Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 114 clinical isolates of Pseudomonas aeruginosa derived from urinary tract infections and their rapid detection by denaturing high-performance liquid chromatography. Int J Antimicrob Agents 40:440\u2013444. https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.06.021","journal-title":"Int J Antimicrob Agents"},{"key":"5006_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10156-012-0455-y","volume":"19","author":"R Salma","year":"2013","unstructured":"Salma R, Dabboussi F, Kassaa I, Khudary R, Hamze M (2013) gyrA and parC mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa from Nini Hospital in North Lebanon. J Infect Chemother off J Jpn Soc Chemother 19:77\u201381. https:\/\/doi.org\/10.1007\/s10156-012-0455-y","journal-title":"J Infect Chemother off J Jpn Soc Chemother"},{"key":"5006_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bgm.2014.03.003","volume":"16","author":"Y-T Wang","year":"2014","unstructured":"Wang Y-T, Lee M-F, Peng C-F (2014) Mutations in the quinolone resistance-determining regions associated with ciprofloxacin resistance in Pseudomonas aeruginosa isolates from Southern Taiwan. Biomark Genomic Med 16:79\u201383. https:\/\/doi.org\/10.1016\/j.bgm.2014.03.003","journal-title":"Biomark Genomic Med"},{"key":"5006_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/IDR.S147581","volume":"11","author":"KV Nguyen","year":"2018","unstructured":"Nguyen KV, Nguyen TV, Nguyen HTT, Le DV (2018) Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam. Infect Drug Resist 11:275\u2013282. https:\/\/doi.org\/10.2147\/IDR.S147581","journal-title":"Infect Drug Resist"},{"key":"5006_CR19","doi-asserted-by":"publisher","unstructured":"Zhao L, Wang S, Li X, He X, Jian L Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa. Antimicrob Resist Infect Control 2020 5;9:124. https:\/\/doi.org\/10.1186\/s13756-020-00793-8","DOI":"10.1186\/s13756-020-00793-8"},{"key":"5006_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijantimicag.2004.11.012","volume":"25","author":"JK Lee","year":"2005","unstructured":"Lee JK, Lee YS, Park YK, Kim BS (2005) Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 25:290\u2013295. https:\/\/doi.org\/10.1016\/j.ijantimicag.2004.11.012","journal-title":"Int J Antimicrob Agents"},{"key":"5006_CR21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.bjm.2016.07.016","volume":"47","author":"R Nouri","year":"2016","unstructured":"Nouri R, Ahangarzadeh Rezaee M, Hasani A, Aghazadeh M, Asgharzadeh M (2016) The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran. Braz J Microbiol Publ Braz Soc Microbiol 47:925\u2013930. https:\/\/doi.org\/10.1016\/j.bjm.2016.07.016","journal-title":"Braz J Microbiol Publ Braz Soc Microbiol"},{"key":"5006_CR22","first-page":"1386","volume":"8","author":"X Yang","year":"2015","unstructured":"Yang X, Xing B, Liang C, Ye Z, Zhang Y (2015) Prevalence and fluoroquinolone resistance of pseudomonas aeruginosa in a hospital of South China. Int J Clin Exp Med 8:1386\u20131390","journal-title":"Int J Clin Exp Med"},{"key":"5006_CR23","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1128\/AAC.45.8.2263-2268.2001","volume":"45","author":"T Akasaka","year":"2001","unstructured":"Akasaka T, Tanaka M, Yamaguchi A, Sato K (2001) Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother 45:2263\u20132268. https:\/\/doi.org\/10.1128\/AAC.45.8.2263-2268.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"5006_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1089\/107662903322762743","volume":"9","author":"H Oh","year":"2003","unstructured":"Oh H, Stenhoff J, Jalal S, Wretlind B (2003) Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains. Microb Drug Resist Larchmt N 9:323\u2013328. https:\/\/doi.org\/10.1089\/107662903322762743","journal-title":"Microb Drug Resist Larchmt N"},{"key":"5006_CR25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/jac\/dki030","volume":"55","author":"P Dupont","year":"2005","unstructured":"Dupont P, Hocquet D, Jeannot K, Chavanet P, Pl\u00e9siat P (2005) Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa. J Antimicrob Chemother 55:518\u2013522. https:\/\/doi.org\/10.1093\/jac\/dki030","journal-title":"J Antimicrob Chemother"},{"key":"5006_CR26","doi-asserted-by":"publisher","first-page":"e02629","DOI":"10.1128\/AAC.02629-17","volume":"2562","author":"VM Ch\u00e1vez-Jacobo","year":"2018","unstructured":"Ch\u00e1vez-Jacobo VM, Hern\u00e1ndez-Ram\u00edrez KC, Romo-Rodr\u00edguez P, P\u00e9rez-Gallardo RV, Campos-Garc\u00eda J, Guti\u00e9rrez-Corona JF et al (2018) CrpP is a novel ciprofloxacin-modifying enzyme encoded by the Pseudomonas aeruginosa pUM505 plasmid. Antimicrob Agents Chemother 2562:e02629\u2013e02617. https:\/\/doi.org\/10.1128\/AAC.02629-17","journal-title":"Antimicrob Agents Chemother"},{"key":"5006_CR27","doi-asserted-by":"publisher","unstructured":"Zhu Z, Yang H, Yin Z, Jing Y, Zhao Y, Fu H et al Diversification and prevalence of the quinolone resistance crpP genes and the crpp-carrying Tn6786-related integrative and conjugative elements in Pseudomonas aeruginosa. Virulence 12:2162\u20132170. https:\/\/doi.org\/10.1080\/21505594.2021.1962160","DOI":"10.1080\/21505594.2021.1962160"},{"key":"5006_CR28","first-page":"250","volume":"69","author":"K Rafiq","year":"2019","unstructured":"Rafiq K, Ahmad K, Ahmad N, Gohar M, Shehzad MA, Saeed MQ (2019) Determination of qnr allele frequencies in Fluoroquinolone resistant Pseudomonas aeruginosa isolated from burn wounds. JPMA J Pak Med Assoc 69:250\u2013252","journal-title":"JPMA J Pak Med Assoc"},{"key":"5006_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10123-021-00220-x","volume":"25","author":"M Nabilou","year":"2022","unstructured":"Nabilou M, Babaeekhou L, Ghane M (2022) Fluoroquinolone resistance contributing mechanisms and genotypes of ciprofloxacin- unsusceptible Pseudomonas aeruginosa strains in Iran: emergence of isolates carrying qnr\/aac(6)-Ib genes. Int Microbiol Off J Span Soc Microbiol 25:405\u2013415. https:\/\/doi.org\/10.1007\/s10123-021-00220-x","journal-title":"Int Microbiol Off J Span Soc Microbiol"},{"key":"5006_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/jmm.0.000873","volume":"68","author":"A Rehman","year":"2019","unstructured":"Rehman A, Patrick WM, Lamont IL (2019) Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem. J Med Microbiol 68:1\u201310. https:\/\/doi.org\/10.1099\/jmm.0.000873","journal-title":"J Med Microbiol"},{"key":"5006_CR31","doi-asserted-by":"publisher","first-page":"15779","DOI":"10.3390\/ijms232415779","volume":"13","author":"AB Lorusso","year":"2022","unstructured":"Lorusso AB, Carrara JA, Barroso CDN, Tuon FF, Faoro H (2022) Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa. Int J Mol Sci 13:23:15779. https:\/\/doi.org\/10.3390\/ijms232415779","journal-title":"Int J Mol Sci"},{"key":"5006_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ijantimicag.2009.05.013","volume":"34","author":"N Gorgani","year":"2009","unstructured":"Gorgani N, Ahlbrand S, Patterson A, Pourmand N (2009) Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosa. Int J Antimicrob Agents 34:414\u2013418. https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.05.013","journal-title":"Int J Antimicrob Agents"},{"key":"5006_CR33","doi-asserted-by":"publisher","unstructured":"Horna G, L\u00f3pez M, Guerra H, Sa\u00e9nz Y, Ruiz J Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa. Sci Rep 2018 7;8:16463. https:\/\/doi.org\/10.1038\/s41598-018-34694-z","DOI":"10.1038\/s41598-018-34694-z"},{"key":"5006_CR34","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1128\/JB.182.5.1410-1414.2000","volume":"182","author":"R Srikumar","year":"2000","unstructured":"Srikumar R, Paul CJ, Poole K (2000) Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-oprM multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol 182:1410\u20131414. https:\/\/doi.org\/10.1128\/JB.182.5.1410-1414.2000","journal-title":"J Bacteriol"},{"key":"5006_CR35","doi-asserted-by":"publisher","first-page":"659808","DOI":"10.3389\/fmicb.2021.659808","volume":"12","author":"Z Ma","year":"2021","unstructured":"Ma Z, Xu C, Zhang X, Wang D, Pan X, Liu H et al (2021) A MexR mutation which confers Aztreonam Resistance to Pseudomonas aeruginosa. Front Microbiol 12:659808. https:\/\/doi.org\/10.3389\/fmicb.2021.659808","journal-title":"Front Microbiol"},{"key":"5006_CR36","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1128\/AAC.50.5.1633-1641.2006","volume":"50","author":"J Quale","year":"2006","unstructured":"Quale J, Bratu S, Gupta J, Landman D (2006) Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 50:1633\u20131641. https:\/\/doi.org\/10.1128\/AAC.50.5.1633-1641.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"5006_CR37","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1128\/JB.185.20.6195-6198.2003","volume":"185","author":"K Saito","year":"2003","unstructured":"Saito K, Akama H, Yoshihara E, Nakae T (2003) Mutations affecting DNA-Binding activity of the MexR repressor of mexr-mexa-mexb-oprm Operon expression. J Bacteriol 185:6195\u20136198. https:\/\/doi.org\/10.1128\/JB.185.20.6195-6198.2003","journal-title":"J Bacteriol"},{"key":"5006_CR38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1128\/AAC.43.2.287","volume":"43","author":"I Ziha-Zarifi","year":"1999","unstructured":"Ziha-Zarifi I, Llanes C, K\u00f6hler T, Pechere JC, Plesiat P (1999) In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob Agents Chemother 43:287\u2013291. https:\/\/doi.org\/10.1128\/AAC.43.2.287","journal-title":"Antimicrob Agents Chemother"},{"key":"5006_CR39","doi-asserted-by":"publisher","first-page":"e0149156","DOI":"10.1371\/journal.pone.0149156","volume":"11","author":"D Choudhury","year":"2016","unstructured":"Choudhury D, Ghose A, Dhar Chanda D, Das Talukdar A, Dutta Choudhury M, Paul D et al (2016) Premature termination of MexR leads to overexpression of MexAB-OprM efflux pump in Pseudomonas aeruginosa in a Tertiary Referral Hospital in India. PLoS ONE 11:e0149156. https:\/\/doi.org\/10.1371\/journal.pone.0149156","journal-title":"PLoS ONE"},{"key":"5006_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1574-6968.1999.tb08709.x","volume":"1","author":"K Saito","year":"1999","unstructured":"Saito K, Yoneyama H, Nakae T (1999) Nalb-type mutations causing the overexpression of the MexAB-OprM efflux pump are located in the mexR gene of the Pseudomonas aeruginosa chromosome. FEMS Microbiol Lett 1:179:67\u201372. https:\/\/doi.org\/10.1111\/j.1574-6968.1999.tb08709.x","journal-title":"FEMS Microbiol Lett"},{"key":"5006_CR41","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1128\/AAC.48.5.1797-1802.2004","volume":"48","author":"C Llanes","year":"2004","unstructured":"Llanes C, Hocquet D, Vogne C, Benali-Baitich D, Neuwirth C, Pl\u00e9siat P (2004) Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob Agents Chemother 48:1797\u20131802. https:\/\/doi.org\/10.1128\/AAC.48.5.1797-1802.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"5006_CR42","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1128\/AAC.41.11.2540","volume":"41","author":"T K\u00f6hler","year":"1997","unstructured":"K\u00f6hler T, Michea-Hamzehpour M, Plesiat P, Kahr AL, Pechere JC (1997) Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother 41:2540\u20132543. https:\/\/doi.org\/10.1128\/AAC.41.11.2540","journal-title":"Antimicrob Agents Chemother"},{"key":"5006_CR43","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1128\/AAC.00503-07","volume":"51","author":"D Hocquet","year":"2007","unstructured":"Hocquet D, Berthelot P, Roussel-Delvallez M, Favre R, Jeannot K, Bajolet O et al (2007) Pseudomonas aeruginosa May Accumulate Drug Resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob Agents Chemother 51:3531\u20133536. https:\/\/doi.org\/10.1128\/AAC.00503-07","journal-title":"Antimicrob Agents Chemother"},{"key":"5006_CR44","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00203-016-1215-7","volume":"198","author":"Y-P Pan","year":"2016","unstructured":"Pan Y-P, Xu Y-H, Wang Z-X, Fang Y-P, Shen J-L (2016) Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa. Arch Microbiol 198:565\u2013571. https:\/\/doi.org\/10.1007\/s00203-016-1215-7","journal-title":"Arch Microbiol"},{"key":"5006_CR45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.patbio.2005.08.005","volume":"53","author":"D Hocquet","year":"2005","unstructured":"Hocquet D, Patry I, Dupont P, Bize M, Jeannot K, Chavanet P et al (2005) [Low-level resistance to fluoroquinolones conferred by efflux overproduction in Pseudomonas aeruginosa: clinical significance and routine detection]. Pathol Biol (Paris) 53:495\u2013499. https:\/\/doi.org\/10.1016\/j.patbio.2005.08.005","journal-title":"Pathol Biol (Paris)"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-05006-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-05006-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-05006-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T14:23:17Z","timestamp":1741098197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-05006-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["5006"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-05006-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}